Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
Clinical trial NCT04606602 · COMPLETED
Trial details
- NCT number
- NCT04606602
- Sponsor
- Silence Therapeutics plc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2023-08-23
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.